{
  "docId": "019de071-3fcc-709d-bd81-493d670a1b54",
  "docSlug": "75c0ef2784bf914c01a48398bea9ca14",
  "documentTitle": "Caribou Biosciences | IPO Presentation Deck | 44 slides",
  "authorId": "caribou-biosciences",
  "authorName": "Caribou Biosciences",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investment_bank",
  "sourceTypeLabel": "Investment bank",
  "presentationDate": "2021-07-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7744917,
  "pageNumber": 38,
  "pageCount": 44,
  "prevPage": 37,
  "nextPage": 39,
  "slideType": "solution",
  "function": "present_solution",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": "The diagram shows a multi-step biological process: Gene editing, two stages of differentiation, and expansion.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de071-3fcc-709d-bd81-493d670a1b54/38",
  "deckHref": "/decks/019de071-3fcc-709d-bd81-493d670a1b54",
  "deckJsonHref": "/decks/019de071-3fcc-709d-bd81-493d670a1b54.json",
  "deckAnchorHref": "/decks/019de071-3fcc-709d-bd81-493d670a1b54#slide-38",
  "components": [
    {
      "bbox": {
        "h": 0.42,
        "w": 0.84,
        "x": 0.08,
        "y": 0.48
      },
      "kind": "diagram",
      "text": "Gene editing (KO/KI) -> Differentiation 1 -> Differentiation 2 -> Expansion -> iNK cells",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2eb1cd68-4dd6-468f-b8ed-2b6051e193ae",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.22,
        "w": 0.92,
        "x": 0.04,
        "y": 0.21
      },
      "kind": "list",
      "text": "CAR-T cells generally have not demonstrated broad, robust anti-tumor activity in solid tumors; Natural killer (NK) cells are allogeneic and inherently target solid tumors and metastases; Edited iNKs, derived from edited iPSCs, are a compelling platform for solid tumor-targeted cell therapy development; Caribou has developed robust differentiation and expansion protocols to derive iNKs from iPSCs",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0ad3f1e7-d585-43ca-b60a-f7bc6b61276a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.92,
        "x": 0.04,
        "y": 0.04
      },
      "kind": "title",
      "text": "CB-020 is an iPSC-derived CAR-NK cell therapy for solid tumor targeting",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "802bd8c2-f214-4df0-9b00-7b0be8a47314",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "AIDA Model",
      "slug": "aida-model",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "0965e97d-f555-49ed-ae27-8ae1e411cc80",
      "evidence": "CAR-T cells generally have not demonstrated broad, robust anti-tumor activity in solid tumors; Natural killer (NK) cells are allogeneic and inherently target solid tumors and metastases; Edited iNKs, derived",
      "confidence": 0.6
    }
  ],
  "frameworks": [
    {
      "name": "process",
      "slug": null,
      "matchId": "d81af3e9-9108-450b-b0b8-12d37c9a15e9",
      "evidence": "The slide depicts a sequential manufacturing process for cell therapy.",
      "confidence": 0.8
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}